The Injective and Orion communities have taken a major step in extending their collaboration with the integration of Injective with the newly released Orion Terminal.
On a high level, Orion is a decentralized platform that aggregates the liquidity, order book depth, and trade pairs from every centralized and decentralized digital asset market. As a chain-agnostic liquidity aggregator, the Orion Terminal will be able to offer decentralized derivatives for users to trade traditional digital assets, exotics, and other derivatives. Furthermore, Orion will leverage Injective’s cross-chain and bridge solutions to further improve user experience when trading across distinct layer one protocols.
Moving forward, the Injective community will focus on integrating decentralized derivatives onto Orion. Using the Orion Terminal, anyone would be able to take part in entirely new financial primitives since a number of cross-chain derivatives markets would only be available via Injective. Functionally, a trader would be able to use Orion’s sleek terminal in order to place a trade which would then get routed into Injective’s shared orderbook.
Another way to think about the user flow is to imagine the Orion Terminal to be part of the Injective relayer ecosystem. Earlier last month, the UpOnly Injective relayer went live. Anyone can access Injective’s orderbook depth and markets via different GUIs and interfaces. The Orion terminal would further bolster this decentralized trading approach by adding to the Injective relayer network.
“We are really excited to join forces with Injective in our common mission of building decentralized technologies for a more inclusive & free financial system that benefits every internet user. Our collaboration will further accelerate growth for the ORN and bring more adoption for our technology stack,” said Alexey Koloskov, Orion Protocol CEO.
Injective will provide Orion users access to a decentralized derivatives platform and Orion will improve Injective’s user experience by giving users access to their cross-chain derivatives through an entirely new interface. As a result, this collaboration will benefit the rapidly growing DeFi industry as a whole.
“Injective and Orion share a common mission of expanding DeFi networks globally while breaking down current financial barriers. We are excited to work with Orion as it enables us to expand one of Injective’s core use cases around cross-chain derivatives to new user bases,” said Eric Chen, Injective Labs CEO.
As the core visions of both Orion and Injective align greatly, Orion and Injective will bring forward a more secure, flexible, and user-friendly experience to the rapidly growing DeFi space.
About Orion Protocol
Built on the most advanced liquidity aggregator ever developed, Orion Protocol aggregates the liquidity of every single crypto exchange into one platform: providing a decentralized gateway to the entire digital asset market. In doing so, Orion is building a protocol on which to bridge the worlds of crypto, traditional finance, and real-world assets.
Injective is the first cross-chain protocol built for decentralized finance applications. On the Injective exchange, anyone can access, create, and trade unlimited DeFi markets such as futures and perpetuals. Developers can also build cross-chain Ethereum-compatible projects that are lightning fast and achieve instant transaction finality. Injective is backed by a prominent group of stakeholders including Binance, Pantera Capital and Mark Cuban.